Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Matthew Marx, MD

Matthew Marx, MD

  • Assistant Professor, CWRU School of Medicine
  • Specialty: Pediatric Critical Care Medicine, Pediatric Emergency Medicine

Biography: Matthew Marx, MD

Expertise

  • Global Health
  • Quality Improvement
  • Sepsis Management

Certifications & Memberships

  • Pediatric Critical Care Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics

Education

Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - Lucile Packard Children's Hospital Stanford (2019 - 2022)

Residency | Pediatrics
Pediatrics - Children's National Medical Center (2015 - 2018)

Medical Education
Tulane University School Of Medicine (2015)

Other Education
Tulane University (2011)

Undergraduate
Tulane University (2010)

About

Matthew H. M. Marx, MD joined the faculty at UH Rainbow Babies and Children’s Hospital in 2022. Dr. Marx earned his undergraduate degree and completed a Master’s degree in Neuroscience at Tulane University, and earned his medical degree at Tulane University School of Medicine. He completed his internship and residency at Children’s National Medical Center, and his Pediatric Critical Care Fellowship at Lucile Packard Children’s Hospital of Stanford University.

Outside his role in the pediatric ICU, his academic interests include Quality Improvement, improving outcomes for patients with sepsis, and global health medicine.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Matthew Marx did not disclose any Outside Relationships with Industry.